LUX Infusion Enhances Hemophilia Treatment Accessibility with Qfitlia Introduction #United_States #Plantation #Hemophilia #Qfitlia #LUX_Infusion
@newsen.bsky.social
@newsen.bsky.socialLUX Infusion Enhances Hemophilia Treatment Accessibility with Qfitlia Introduction #United_States #Plantation #Hemophilia #Qfitlia #LUX_Infusion
@meryldl.bsky.socialMagazine articles often point out flaws in our medical and drug systems, so it was nice to write about a glowing success in my latest NatGeo piece: breakthrough treatments for #hemophilia, which have transformed what it means to have the disease. Paywalled, but if you DM me I'll send a PDF.
@haemophamicus.bsky.social
@haemophamicus.bsky.social
@haemophamicus.bsky.social
@haemophamicus.bsky.socialThe #EHC2026 conference is taking place in #Istanbul today—three days of invaluable experience sharing, new knowledge, and #bleedingdisorders community networking across Europe! 🌍🤝
#hemophilia 🇹🇷 @ehc-news.bsky.social
@fionarobinsonphd.bsky.socialExplore the journey to a once-weekly treatment for people with hemophilia A and their outcomes through a review of real-world patient cases in this week's NBDF Wednesday Webinar, sponsored by Sanofi.
Sept 30, 2PM ET
bleeding.org/events
#RealWorldData
#Hemophilia
#Altuviiio
@novomedus.bsky.socialEvery person living with #hemophilia has a story worth hearing. At Novo, we are committed to advancing research and deepening our understanding of the experiences that shape life with hemophilia. Join us at #inSPire2026 to learn how we are helping shape the future of hemophilia care.
@gibbler12.bsky.socialsevere #hemophilia kinda be like minecraft ultra hardcore mode
@hematologyadvisor.bsky.socialA study in Hematology Reports highlights a growing divide in global #Hemophilia care: while advanced therapies transform outcomes, many patients globally still lack basic access to care and diagnosis.
Read more: https://bit.ly/4yQ60zk
@samelsonjones.bsky.socialAs #hemophilia treatments become more sophisticated, understanding the role of the dysfunctional F9 variant becomes more important:
Factor IX gene variants may influence the pharmacokinetic profile of patients with hemophilia B treated www.jthjournal.org/article/S153...
@pharmalot.bsky.socialPharmalot.. Pharmalittle.. Good Morning: We’re reading about licensing deals with China, making drugs in space, and more news.. statnews.com/pharmalot/20... #pharma #China #FDA #Trump #Medicaid #Anthropic #hemophilia #UK #medicines
@fds3rd.bsky.social#Hemophilia A Treatment Pioneers Win Lasker Award
More than a decade of work led to a dual-targeting antibody mimic of a blood-clotting protein to treat hemophilia A. Three scientists received a #LaskerAward for their efforts
#Immunology #Science
@fds.wsocial.eu#Hemophilia A Treatment Pioneers Win Lasker Award
More than a decade of work led to a dual-targeting antibody mimic of a blood-clotting protein to treat hemophilia A. Three scientists received a #LaskerAward for their efforts
#Immunology #Science
@hemehub.bsky.social🩸 HemeHub is honored to have Adam Cuker, MD, MS, on our Scientific Advisory Board.
A leader in hematology, Dr. Cuker brings expertise in hemophilia, thrombosis, and blood disorders to help advance HemeHub’s mission.
#HemeHub #Hematology #Hemophilia #Thrombosis #BloodDisorders
@laskerfdn.bsky.social“Japanese sleep scientist Masashi Yanagisawa and three Japanese researchers who developed a #hemophilia treatment drug at Chugai Pharmaceutical Co. won Lasker Awards in medicine on Wednesday,” Kyodo News Official reports.
共同通信北米３支局 Kyodo News North America #Lasker2026 #LaskerAward 🧪
@fds3rd.bsky.social#Hemophilia A Treatment Pioneers Win #LaskerAward
#Immunology #Science
@fds.wsocial.eu#Hemophilia A Treatment Pioneers Win #LaskerAward
#Immunology #Science
@rleutybiotech.bsky.socialSleepy dogs, problem bleeds and Michael J. Fox's foundation land 'American Nobels' www.bizjournals.com/sanfrancisco...
@stanforduniversity.bsky.social
@laskerfdn.bsky.social
#narcolepsy #hemophilia #LaskerAwards
@laskerfdn.bsky.socialCongratulations to 2026 #LaskerAward winners Kunihiro Hattori, Tomoyuki Igawa & Takehisa Kitazawa! For invention of a bispecific antibody that joins blood clotting Factors IX and X, restoring deficient Factor VIII activity in #hemophilia A and preventing severe bleeding in this genetic disorder. 🧪
